Pharmacotherapy and noninvasive neurostimulation for neuropathic pain
- PMID: 38636787
- DOI: 10.1016/j.lpm.2024.104233
Pharmacotherapy and noninvasive neurostimulation for neuropathic pain
Abstract
Neuropathic pain poses a significant challenge due to its complex mechanisms, necessitating specific treatments. In recent decades, significant progress has been made in the clinical research of neuropathic pain, marking a shift from empirical strategies to evidence-based medicine in its management. This review outlines both pharmacological and non-pharmacological interventions. Antidepressants (tricyclic and serotonin-noradrenaline reuptake inhibitors), antiepileptics (gabapentin, pregabalin), and topical agents constitute the main pharmacological treatments. These approaches target peripheral or central mechanisms associated with neuropathic pain. Noninvasive neurostimulation, including transcutaneous electrical nerve stimulation (TENS) and repetitive transcranial magnetic stimulation (rTMS), provides non-pharmacological alternatives. However, challenges persist in effectively targeting existing medications and developing drugs that act on novel targets, necessitating innovative therapeutic strategies.
Keywords: Antidepressants; Antiepileptics; Neuropathic pain; Neurostimulation; Noninvasive brain stimulation; Opioids; Pharmacological treatments; Topical analgesics.
Copyright © 2024 Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of competing interest Over the past 3 years, Nadine Attal has received fees for advisory boards or speakers bureau from Pfizer, Viatris, Novartis, Grunenthal, Upsa, Merz, Biogen outside the submitted work. Annachiara Spagna has nothing to disclose.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
